Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 4, 1994 - Issue 10
Submit an article Journal homepage
5
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Overview: Central & Peripheral Nervous System: Recent advances in antipsychotic research

Mark E McDonnell Medicinal Chemistry Department, RW Johnson Pharmaceutical Research Institute, Spring House, PA, 19477, USA
&
Allen B Reitz Medicinal Chemistry Department, RW Johnson Pharmaceutical Research Institute, Spring House, PA, 19477, USA
Pages 1221-1231 | Published online: 03 Mar 2008

References to Primary Literature

  • SWAZEY JP: Chloropromazine in therapy a study of thera- peutic ink,reention (1974). The MIT Press, Cambridge, Mas-sachusetts.
  • MELTZER HY: In: Psychopharmacology: The third generation of progress (1987). Raven Press, New York, 1987.
  • REYNOLDS GP: Developments in the drug treatment of schizophrenia. Trends Pharm. Sci. (1992) 13: 116–121.
  • WEST SA, NEMEROFF CB: Atypical antipsychotic drugs: current status and future directions. Drugs Today (1993) 29: 183–188.
  • SIBLEY DR, MONSMA FJA, JR: Molecular biology of dopamine receptors. Trends Pharm. Sci. (1992) 13: 61–69.
  • SEEMAN P: Dopamine receptor sequences: therapeutic levels of neuroleptics occupy Drreceptors, clozapine occupies 134. Neuropsychop harm. (1992) 7: 261–284. Recent findings concerning the specificity of dopamine receptor subtypes.
  • SEEMAN P, GUAN H-C, VAN TOL HUM: Dopamine D4 receptors elevated in schizophrenia. Nature (1993) 365: 441–445. Receptor composition in schizophrenics elucidated.
  • WIKSTROM H, SVENSSON K: Advances in central sero-tonergics. In: Ann. Rep. Med. Chem (1989). 25: 41–50, J BRISTOL (Ed.) Acad. Press.
  • GOTHERT M: 5-Hydroxytryptamine receptors. Arn-zeim.-Forsch. (1992) 42: 238–246.
  • CIPOLLINA JA: Novel antipsychotic agents: a patent overview - 1991. Cum. Opin. Tber. Pat. (1992) 2: 485–499.
  • HOWARD HR, SEEGER TF: Novel antipsychotics. In: Ann.Rep. Med. Chem. (1993). 28: 39–47, J BRISTOL (Ed.), Acad. Press.
  • TRICKLEBANK MD, BRISTOW U, HUTSON PH: Alternative approaches to the discovery of novel antipsychotic agents. Prog. Drug. Res. (1992) 38: 299–336.
  • BOTTCHER H, BARNICICEL G, HAUSBERG H-H, HAASE AF, SEYFRIED CA, EIERMANN V: Synthesis and dopaminergic activity of some 341,2,3,6-tetrahydro- 1-pyridylalkyl)in-doles. A novel conformational model to explain struc-ture-activity relationships. J. Med. Chem. (1992) 35: 4020–4026.
  • TUPPER DE, PULLAR IA, CLEMENS JA, FAIRHURST J, RISIUSFC, TIMMS GH, WEDLEY S: Synthesis and dopamine antagonist activity of 2-thioether derivatives of the ergoline ring system. J. Med. Chem. (1993) 36: 912–918.
  • SOKOLOFF P, MARTRES M-P, GIROS B, BOUTHENET M-L, SCHNX7ARTZ J-C: The third dopamine receptor (1)3) as a novel target for antipsychotics. Biochem. Pharmacol. 1992, 43, 659–666.
  • NEUMEYER JL, KULA NS, BALDESSARINI RJ, BAINDUR N: Stereoisomeric probes for the Di dopamine receptor: synthesis and characterization of R-(+) and S-(-) enan-tiomers of 3-ally1-7,8-dihydroxy-l-phenyl-2,3,4,5-tetra-hydro-1H-3-lbenzazepine and its 6-bromo analogue. I Med. Chem. (1992) 35: 1466–1471.
  • CHIDESTER CG, UN CH, LAHTI RA, HAADSMA-SVENSSON SR, SMITH MW: Comparison of 5-HTiA and dopamine 132 pharmacophores. X-ray structures and affinities of con-fonnationally constrained ligands. J. Med. Chem. (1993) 36: 1301–1315. Recent pharmacophore study of the serotonin and dopamine recep-tors.
  • REITZ AB, BENNETT DJ, BLUM PS, CODD EE, MARYANOFF CA, ORTEGON ME, RENZI MJ, SCOTT MK, SHANK RP, VAUGHT JL: A new arylpiperazine antipsychotic with high 1:02/D3/5-11T1VatA-adrenergic affinity and a low potential for extrapyramidal effects. J. Med. Chem. (1994) 37:
  • HARTIG PR: Molecular biology of 5-HT receptors. Trends Pharmacol. Sci. (1989) 10: 64–69.
  • PEROUTICA SJ: 5-Hydroxytryptamine receptor subtypes. Pharmacol. Toxicol. (Copenhagen) (1990) 67: 373–383.
  • RABASSEDA X, MEALY N, PEUSKENS J: Risperidone: A novel antipsychotic for schizophrenia with broad effi-wypa paa.a.man, aa G. • g•, vir Latest findings on dopamine subtype homology. 1230 Central & Peripheral Nervous System - Overview cacy and reduced potential for extrapyramidal symp-toms. Drugs of Today (1993) 29: 535–553.
  • COWEN PJ: Serotonin receptor subtypes: implications for psychopharmacology. Br. J. Psychiatry (1992) 159\(suppl 12): 7–14. Effects of modulating the serotonin receptor in treating schizophre-nia.
  • WALKER JM, BOWEN WI), WALKER FO, MATSUMOTO RR,DE COSTA B, RICE KC: a Receptors:biology and function. Pharmacol. Rev. (1990) 42: 355–402.
  • KAISER C, PONTECORVO MJ, MEWSHAW RE: a Receptorligands: function and activity. Neurotransmission (1991) VII:1–5.
  • NAIR NPV, LAL S, BLOOM DM: Cholecystokinin and schizophrenia. Fog. Brain Res. (1986) 65: 237–258.
  • WANG RY: Cholecystokinin, dopamine, and schizo-phrenia: recent progress and current problems. Ann. NY Acad. Sci. (1988) 537: 362–379.
  • DEUTSCH SI, MASTROPAOLO J, SCHWARTZ BL, ROSSE RB, MORIHISA JM: A 'Glutamatergic hypothesis' of schizo-phrenia. Qin. Neuropharmacol. (1989) 12: 1–13.
  • CARLSSON M, CARLSSON A: Interactions between glu-tamertergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurasa. (1990) 13: 272–276. References to Patent Literature

References to Patent Literature

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.